Patrick Arnold’s ex-girlfriend, Kelcey Dalton, testified as a witness in cyclist Tammy Thomas steroid case. She told the court that Patrick Arnold (of Ergopharm) made very little profit from the sell of performance enhancing drugs (which were classified as “unapproved new drugs” prior to the Anabolic Steroid Control Act of 2004) [“Witness: Little Profit for Steroid Maker,” March 27].
The sums of money Arnold was making were “very low,” she said. “I think we should have charged more.”
Patrick confirmed via email that he only made $15-20 thousand over the course of the THREE YEARS he provided tetrahydrogestrinone (THG) and norbolethone to elite athletes while working with Victor Conte. The government calls a $5,000 a year operation a major steroid bust?!
While the BALCO steroid bust involving undetectable performance enhancing drugs was a big deal to Patrick Arnold et al and the athletes involved, the dismantling of BALCO had practically no direct impact on the commercial trade of anabolic steroids on the black market. However, the role of the BALCO scandal as the impetus for the current steroid hysteria can not be underestimated.
About the author
Millard writes about anabolic steroids and performance enhancing drugs and their use and impact in sport and society. He discusses the medical and non-medical uses of anabolic-androgenic steroids while advocating a harm reduction approach to steroid education.
No replies yet
Loading new replies...
Join the full discussion at the MESO-Rx →